About Casper Pharma
Casper Pharma is a Healthcare company based in East Brunswick (United States) founded in 2016, and was acquired by Suven Pharmaceuticals in April 2022. Specialty pharmaceuticals in key therapeutic areas are developed and commercialized. It operates on a Direct-to-Consumer (D2C) and B2B2C model. Casper Pharma offers products and services including Triglide, Gastrointestinal Therapies, Urological Medications, Pain Management Solutions, and Ophthalmic Treatments. Its focus areas include Pharmaceuticals and Specialty Pharmaceuticals.
Company details
Casper Pharma is engaged in the development, acquisition, and commercialization of specialty pharmaceuticals aimed at improving patient lives. The company operates within cardiovascular, gastrointestinal, urological, pain management, and ophthalmic markets. Solutions are provided through a global network, leveraging innovation and technology to address unmet medical needs. A commitment to high-quality, cost-effective therapies is maintained to serve healthcare communities and enhance patient outcomes.
- Headquarters East Brunswick, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website casperpharma.com
- Acquired by Suven Pharmaceuticals (Apr 2022)
- Annual Revenue$1.24 M (USD)526as on Mar 31, 2022
- Net Profit-$1.96 M (USD)-117as on Mar 31, 2022
- Investors
- Acquired bySuven Pharmaceuticals
(Apr 2022)
Products & Services of Casper Pharma
Casper Pharma offers a comprehensive portfolio of products and services, including Triglide, Gastrointestinal Therapies, Urological Medications, Pain Management Solutions, and Ophthalmic Treatments.
Medication developed for cardiovascular health management and treatment.
Therapies provided for gastrointestinal conditions and patient care.
Medications offered for urological issues and health improvement.
Solutions created for pain management and patient relief.
Treatments designed for ophthalmic conditions and vision care.
Investors in Casper Pharma
Casper Pharma has secured backing from 1 investor. Prominent investors backing the company include Suven Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Contract manufacturing and development of APIs and formulations are provided. | 1989 | suvenpharm.com | Hyderabad, India |
Investor details for Casper Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Casper Pharma
3 people are tracked at Casper Pharma (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Pavan G. | VP Finance | Leadership |
Vimal Kavuru | CEO | Leadership |
Mario Solberg | Information Technology Manager | Team |
Complete people profiles for Casper Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Casper Pharma
2 dated milestones of Casper Pharma across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Casper Pharma is founded.
- Exit Acquired by Suven Pharmaceuticals.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Casper Pharma (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Casper Pharma
Casper Pharma was founded in 2016.
Casper Pharma is headquartered in East Brunswick, United States. It is registered at East Brunswick, New Jersey, United States.
Annual revenue of Casper Pharma is $1.24M as on Mar 31, 2022.
Casper Pharma is engaged in the development, acquisition, and commercialization of specialty pharmaceuticals aimed at improving patient lives. The company operates within cardiovascular, gastrointestinal, urological, pain management, and ophthalmic markets. Solutions are provided through a global network, leveraging innovation and technology to address unmet medical needs. A commitment to high-quality, cost-effective therapies is maintained to serve healthcare communities and enhance patient outcomes.
Casper Pharma offers Triglide, Gastrointestinal Therapies, Urological Medications, Pain Management Solutions, and Ophthalmic Treatments.
Casper Pharma has 1 investor. Key investors include Suven Pharma.
Yes. Casper Pharma was acquired by Suven Pharmaceuticals in April 2022.